Patients who had residual neck disease after treatment for a primary head and neck squamous carcinoma and then underwent neck dissection had comparable survival rates to those who had their disease resolved after their initial chemotherapy and radiation treatment, according to a retrospective analysis from researchers at the University of Louisville in Kentucky presented here Jan. 27.
The system of clinical cancer research, including that of head and neck cancer, is in need of an overhaul, but steps are being taken that might lead to more efficient work and will hopefully mean more medical breakthroughs, said David Schuller, MD, the chair in cancer research at the Ohio State University College of Medicine in Columbus, at the Triological Society’s Combined Sections Meeting, held here on Jan. 27.
What are the trigger events that lead to detection of otherwise asymptomatic thyroid cancers? Background: The incidence of thyroid cancer has more than doubled in the past 30 years, but mortality […]
Does young age adversely affect prognosis for oral squamous cell carcinoma? Background: Squamous cell carcinoma in young patients (<40 years of age) is believed to have an etiology that is distinct […]
Part 1 of a series
A leading endoscopic surgeon said that removing complex esthesioneuro blastomas can be achieved using accepted oncological principles, and that the early results appear comparable to outcomes achieved with conventional surgery.
A meta-analysis of the literature suggests that oncologic and voice quality results are similar if patients with early-stage glottic cancer are treated with either transoral laser surgery or external beam radiotherapy.
Patients with head and neck cancer treated with surgery and/or radiation often experience pain, shoulder dysfunction, and xerostomia.
Better chemotherapy and aggressive chemoradiation have contributed to improved locoregional control and survival for head and neck cancer.